Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
YN-1 Probe Info |
![]() |
N.A. | LDD0447 | [1] | |
PAL-AfBPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
STS-1 Probe Info |
![]() |
N.A. | LDD0137 | [2] | |
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Phase 3
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Lampalizumab | Antibody | DM7Z6Y | |||
Phase 2
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Anti-factor D | Antibody | D08ZDI | |||
| Ach-4471 | . | D0C9MA | |||
Investigative
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| 34-dichloroisocoumarin | Small molecular drug | DB04459 | |||
| Example 373 [Wo2012093101] | Small molecular drug | D04MIN | |||
| 2-aminobenzyl Alcohol | . | DB03058 | |||
| Hc3-1496 | . | D0P8LR | |||
References


